在胆道癌症中的KRAS等位基变异 胆道癌症
Gordon Taylor Moffat1, Zishuo Ian Hu2, Funda Meric-Bernstam3
1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
KRAS等位基变异在胆道癌 (BTCs) 中很常见,特别是在周周和肝外亚型中. G12D变异显示了最长的平均整体存活期,为这个患者群体提供了潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 癌症研究 癌症研究
背景情况:
- 胆道癌 (BTC) 呈现可操作的分子变异,包括KRAS变异,在20-30%的病例中存在.
- 多种KRAS抑制剂正在临床研究中,突出了针对这些突变的治疗潜力.
研究的目的:
- 描述基因组景观,免疫表型和KRAS突变BTC的生存结果.
- 在BTC患者中确定常见KRAS等位基变异的中位整体存活 (mOS).
主要方法:
- 一项回顾性多中心队列研究分析了来自7457名BTC患者 (2017-2022) 的临床和下一代测序数据.
- 对于KRAS突变BTC的患者,计算了总生存时间的中位数,并对常见的等位基因变异进行了具体分析.
主要成果:
- KRAS突变在周围 (28.6%) 和肝外 (36.1%) 胆管癌中普遍存在.
- G12D变种 (41%的KRAS突变) 的mOS最高 (25.1个月),其次是Q61H (22.8个月) 和G12V (17.8个月).
- 与野生型瘤相比,KRAS突变的BTC通常具有较低的瘤突变负担和更具免疫性炎症的微环境.
结论:
- KRAS等位基因变异在BTC中是常见的和潜在的可操作的基因组变异,特别是在周围和肝外亚型中.
- 这些发现有助于了解KRAS突变BTC的基因组和免疫特征,有助于个性化治疗规划.
更多相关视频
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
11:20Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
Published on: March 21, 2018
相关概念视频
The Ras Gene
Ras is a...
RNA Splicing
Cancers Originate from Somatic Mutations in a Single Cell
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
